Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A modified BPaL regimen for tuberculosis treatment replaces linezolid with inhaled spectinamides.
Journal: eLife
Published: October 08, 2024
A Modified BPaL Regimen for Tuberculosis Treatment replaces Linezolid with Inhaled Spectinamides.
Journal: bioRxiv : the preprint server for biology
Published: November 28, 2023
Intrapulmonary Treatment with Mycobacteriophage LysB Rapidly Reduces Mycobacterium abscessus Burden.
Intrapulmonary Treatment with Mycobacteriophage LysB Rapidly Reduces Mycobacterium abscessus Burden.
Journal: Antimicrobial agents and chemotherapy
Published: May 08, 2023
Role of succinyl substituents in the mannose-capping of lipoarabinomannan and control of inflammation in Mycobacterium tuberculosis infection.
Journal: PLoS pathogens
Published: November 23, 2022
Microbiological profile, preclinical pharmacokinetics and efficacy of CRS0393, a novel antimycobacterial agent targeting MmpL3.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: September 29, 2022
Respirable Clofazimine Particles Produced by Air Jet Milling Technique Are Efficacious in Treatment of BALB/c Mice with Chronic Mycobacterium tuberculosis Infection.
Journal: Antimicrobial agents and chemotherapy
Published: August 09, 2022
Preclinical Evaluation of Inhalational Spectinamide-1599 Therapy against Tuberculosis.
Journal: ACS infectious diseases
Published: September 21, 2021
Inhaled tigecycline is effective against Mycobacterium abscessus in vitro and in vivo.
Journal: The Journal of antimicrobial chemotherapy
Published: January 08, 2020
Sterilization of Mycobacterium tuberculosis infected samples using methanol preserves anti-tuberculosis drugs for subsequent pharmacological testing studies.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: March 14, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026